May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
Mar 31, 2020
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
Dec 16, 2019
Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH
Oct 26, 2019
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)
Oct 03, 2019
Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero's 3D InSight(TM) Human Liver Disease platform
Aug 29, 2019
Global $61.6 Bn Non-Alcoholic Steatohepatitis (NASH) Drugs Market to 2028
Jun 11, 2019
NASH kNOWledge Joins Global International Nonalcoholic Steatohepatitis (NASH) DAY to Raise Disease Awareness
Mar 27, 2019
DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic Steatohepatitis (NASH)
Mar 27, 2019
Cirius Therapeutics to Present Preclinical Data for Lead Drug Candidate in NASH at The International Liver Congress
Mar 26, 2019
The Kinetix Group and Consulting at McCann Health's Research Report on Quality Measures for Nonalcoholic Steatohepatitis (NASH) to Be Presented at ISPOR­ 2019
Feb 13, 2019
Second Edition of International NASH Day Announced Under a New Coalition Leadership
Feb 04, 2019
Global Non-Alcoholic Steatohepatitis (NASH) Market 2018-2026: Increased Understanding of Potential Treatment Algorithms for NASH Patients With Cirrhosis
Jan 23, 2019
Global Non-Alcoholic Steatohepatitis (NASH) Pipeline Therapeutics Report 2019
Nov 27, 2018
Nonalcoholic Steatohepatitis (NASH) Market Analysis, Market size, Epidemiology, Leading companies and Competitive Analysis by DelveInsight
Nov 08, 2018
Kayla Buenrostro's New Book "The Lost Princess" is about Nash Winters, a Senior in High School, and her Unexpected Entrapment in Another World
Aug 23, 2018
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with Echosens Launches a Real World Evidence Model
Aug 06, 2018
IQ4I Research and Consultancy Published New Pipeline Analysis on 'Non-Alcoholic SteatoHepataitis (NASH)'
Aug 03, 2018
Data Projects the NASH Market Will Eclipse USD 21 Billion by 2025
Jul 31, 2018
Non-Alcoholic Steatohepatitis (NASH) Market to Witness a CAGR of 58.4% During 2021 to 2025 - Allied Market Research
Jul 05, 2018
HistoIndex Welcomes Its New CEO on Board